Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Virtual Reality-Assisted Nursing Intervention During Intrauterine Device Insertion (VR-IUD)

30 ottobre 2026 aggiornato da: YASEMİN ATEŞEYAN, Mersin University

Effect of Virtual Reality-Assisted Nursing Intervention on Pain and Anxiety During Intrauterine Device Insertion: A Randomized Controlled Trial

This randomized controlled trial evaluated the effects of a virtual reality-supported nursing intervention based on Kolcaba's Comfort Theory on women's comfort, emotional state, pain and physiological parameters during intrauterine device insertion. Seventy women attending a family planning clinic were individually randomized by lottery to a virtual reality group, who received the intervention in addition to routine care, or to a control group, who received routine care only.

Panoramica dello studio

Descrizione dettagliata

Study hypotheses

Compared with the control group (routine care without virtual reality), women receiving the virtual reality-assisted nursing intervention (experimental group):

  • experience a lower level of pain during the procedure;
  • experience lower levels of anxiety during the procedure;
  • exhibit a lower stress response in physiological parameters (pulse rate, blood pressure and respiratory rate);
  • experience higher levels of comfort during the procedure. Condition: Pain, anxiety, physiological parameters and comfort of women during intrauterine device (IUD) insertion Intervention: Virtual reality-assisted nursing intervention Population: Women who have decided to have an IUD inserted Note on outcomes: In the initial registration, pain was erroneously listed as the primary outcome. The primary outcome of this trial is overall comfort, measured with the General Comfort Scale total score before and after the procedure. This was corrected on October 30, 2026. Pain was assessed at all planned time points and is reported as a secondary outcome.

Study Design Study type: Interventional (clinical trial) Design: Single-center, prospective, two-arm, parallel-group randomized controlled trial Allocation: Randomized (1:1) Masking: None (open label). Because of the nature of the intervention, participants, the nurse researcher delivering the intervention and the practitioners could not be blinded. Data were coded before analysis, and the analyses were performed by a researcher who was not involved in data collection.

Setting: Family planning outpatient clinic of a women's and children's hospital, Gaziantep, Türkiye Study period: October 2024 to March 2025 Sample Size The sample size was calculated with G*Power 3.1.9.4 for a repeated-measures analysis of variance (two groups, two measurements), with a significance level of 5% (alpha = 0.05), a power of 95% and an effect size of f = 0.40. The minimum required sample was 64 women (32 per group). To allow for possible data loss, the target sample was set at 70 women (35 per group).

Participant Flow Eighty-nine women who agreed to participate were assessed for eligibility. Nineteen did not meet the eligibility criteria (visual impairment, n = 5; psychiatric disorder, n = 2; severe dizziness, n = 4; analgesic use before the procedure, n = 8). The remaining 70 women were randomized (experimental group = 35, control group = 35). No participant withdrew or was lost to follow-up, and all 70 women were included in the analysis.

Randomization and Groups Participants were individually randomized in a 1:1 ratio to the experimental or control group by lottery. Seventy identical slips of white paper, 35 labeled "experimental group" and 35 labeled "control group," were placed in a bag. After giving written informed consent and completing the baseline assessments, and before IUD insertion, each eligible woman drew one slip from the bag; drawn slips were not returned.

Given the nature of the intervention, information exchange between participants (contamination) could have influenced the results. To minimize this risk, women waited in a separate waiting area before the procedure, were called into the procedure room individually and, after the procedure, left the clinic through a separate exit that did not lead back to the waiting area.

Baseline characteristics of the groups were compared statistically, and baseline-adjusted analyses were used to account for any imbalances.

Note: An earlier version of this record described day-based allocation. This description has been corrected to reflect the individual lottery-based randomization that was actually implemented.

Intervention Experimental group (virtual reality group): In addition to routine care, women received a virtual reality-assisted nursing intervention based on Kolcaba's Comfort Theory. The nurse researcher prepared each woman for the procedure and used virtual reality to increase her comfort and reduce her anxiety. Women watched a nature-themed 360-degree video (water, forest and sky scenes) with soothing music, lasting approximately 6 minutes, through a virtual reality headset. The video was started 2 minutes before insertion and continued until it ended after insertion. The intervention was designed as a non-pharmacological nursing intervention to divert attention away from the procedure and to reduce pain and anxiety.

Control group (routine care): Women received routine care according to the clinic's standard practice, without virtual reality or any other study intervention.

All participants received a copper IUD inserted by the practitioners on duty. Materials

  1. Virtual reality headset: Samsung Gear VR (SM-R321NZWATUR), used with a smartphone
  2. Virtual reality video: "Virtual Nature 360° - 5K Nature Meditation for Daydream, Oculus, Gear VR," featuring nature scenes accompanied by calming music Data Collection Data were collected by trained researchers through face-to-face interviews in three phases; each session took approximately 15 to 20 minutes.

Before the procedure: Descriptive Characteristics Questionnaire; General Comfort Scale; visual analogue scales for anticipated pain, tension, fear/anxiety, irritability and contentment; blood pressure, pulse rate and respiratory rate. Allocation slips were drawn after these assessments.

During the procedure: pain (visual analogue scale) and pulse rate immediately after speculum insertion, tenaculum application and IUD placement.

After the procedure (5 minutes): blood pressure, pulse rate and respiratory rate; visual analogue scales for pain, tension, fear/anxiety, irritability and contentment; General Comfort Scale. Procedure duration (minutes), practitioner satisfaction and adverse events (such as dizziness, nausea and headset discomfort) were also recorded.

Vital signs were measured in both groups by the same researcher with the same device.

Data Collection Instruments Descriptive Characteristics Questionnaire: Prepared by the researchers on the basis of the literature; it covers age, education, employment, income, health insurance, obstetric history, current contraceptive use and its duration, previous IUD use, the person who decided on IUD use and negative information about IUDs received from the social environment.

General Comfort Scale: Developed by Kolcaba and adapted into Turkish, the scale consists of 48 four-point Likert-type items in three subscales (relief, ease and transcendence). Negative items are reverse-scored. Total scores range from 48 to 192, and higher scores indicate greater comfort. Cronbach's alpha was 0.85 for the Turkish version.

Visual analogue scales: Tension, fear/anxiety, irritability and contentment were each rated on a 100-mm scale from 0 (none) to 100 (most intense). Pain was rated on a 100-mm scale from 0 (no pain) to 100 (worst imaginable pain). Before the procedure, women rated on the same scale the pain they expected to feel during insertion (anticipated pain). The practitioner rated satisfaction with the procedure on a 100-mm scale from 0 (not at all satisfied) to 100 (completely satisfied).

Ethics Ethical approval was obtained from the SANKO University Clinical Research Ethics Committee (Decision No. 2023/24; December 21, 2023), together with institutional permission. The study followed the Declaration of Helsinki. Participants were informed about the aims and procedures of the study, and written informed consent was obtained from all participants.

Statistical Analysis Data were analyzed with IBM SPSS Statistics 25.0. Normality was assessed by skewness and kurtosis, homogeneity of variances by Levene's test and homogeneity of covariance matrices by Box's M test. Baseline characteristics were compared with the chi-square, Fisher's exact or Fisher-Freeman-Halton exact test and the independent-samples t-test, and standardized mean differences were calculated.

Intervention effects were estimated with analysis of covariance (ANCOVA), using the post-procedure score as the dependent variable, group as the fixed factor and the baseline score as the covariate (anticipated pain for pain after the procedure). ANCOVA assumptions (linearity, homogeneity of regression slopes, normality and homogeneity of residuals, influential observations) were checked. Sensitivity analyses included additional covariates for imbalanced baseline characteristics, heteroscedasticity-consistent (HC3) standard errors and a mixed-design repeated-measures ANOVA (group x time).

Variables not suitable for parametric testing (irritability, pain, procedure duration and practitioner satisfaction) were compared with the Mann-Whitney U test, and within-group change in pain with the Wilcoxon signed-rank test. Intraprocedural pain was compared with the Mann-Whitney U test and intraprocedural pulse rate with ANCOVA adjusted for baseline pulse rate. All tests were two-sided, and p < 0.05 was considered significant.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

70

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Femmina

Descrizione

Inclusion Criteria:

Aged 18 years or older Sexually active Decided to undergo intrauterine device insertion after routine contraceptive counseling Suitable candidate for intrauterine device insertion on gynecological examination No communication difficulties

Exclusion Criteria:

Visual or hearing impairment Diagnosed psychiatric disorder Severe facial injury History of epilepsy or severe dizziness Analgesic use before the procedure Any contraindication to intrauterine device insertion

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Terapia di supporto
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Virtual reality group

Intervention Type: Behavioral Intervention Name: Virtual reality-supported nursing intervention Other Intervention Names: VR-supported nursing intervention Assign to Arm: Experimental: Virtual reality group Description:Routine care plus the virtual reality-supported nursing intervention during IUD insertion.

In addition to routine care, women received a virtual reality-supported nursing intervention based on Kolcaba's Comfort Theory. The nurse prepared each woman for the procedure and used virtual reality to increase comfort and reduce anxiety. Women watched a nature-themed 360-degree video with relaxing music (approximately 6 minutes) through a head-mounted display (Samsung Gear VR), started 2 minutes before insertion and continued until the video ended.

Intervention Name: Virtual Reality Intervention

Description:

Participants in the experimental group received a virtual reality-assisted nursing intervention during intrauterine device insertion. A virtual reality headset was used to present a 3D immersive video including relaxing natural scenes and calming background music. The intervention was applied continuously throughout the procedure to distract attention from the procedure and reduce pain and anxiety.

Intervention Name: Routine Care

Description:

Participants in the control group received routine care during intrauterine device insertion without the use of virtual reality or any additional distraction method.

Nessun intervento: Control Group

Arm Title Control group Arm Type No Intervention Arm Description Routine care according to the clinic's standard practice, without virtual reality or any other study intervention.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
General Comfort Scale total score
Lasso di tempo: Before IUD insertion (baseline) and 5 minutes after the procedure

Overall comfort was measured with the Turkish version of Kolcaba's General Comfort Scale, which consists of 48 items rated on a four-point Likert scale. Total scores range from 48 to 192, with higher scores indicating greater comfort.

Before IUD insertion (baseline) and 5 minutes after the procedure

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
General Comfort Scale subscale scores (relief, ease and transcendence)
Lasso di tempo: Before IUD insertion (baseline) and 5 minutes after the procedure

Scores of the relief, ease and transcendence subscales of the General Comfort Scale; higher scores indicate greater comfort.

Before IUD insertion (baseline) and 5 minutes after the procedure
Emotional state scores (tension, fear/anxiety, irritability and contentment)
Lasso di tempo: Before IUD insertion (baseline) and 5 minutes after the procedure

Each emotional state was rated on a single-item 100-mm visual analog scale ranging from 0 (none) to 100 (most intense).

Before IUD insertion (baseline) and 5 minutes after the procedure
Pain intensity (visual analog scale)
Lasso di tempo: Before the procedure (anticipated pain); immediately after speculum insertion, tenaculum application and IUD placement; and 5 minutes after the procedure

Pain was rated on a 100-mm visual analog scale from 0 (no pain) to 100 (worst imaginable pain). Before the procedure, women rated the pain they expected to feel during insertion (anticipated pain).

Before the procedure (anticipated pain); immediately after speculum insertion, tenaculum application and IUD placement; and 5 minutes after the procedure
Pulse rate (beats per minute
Lasso di tempo: Before the procedure; immediately after speculum insertion, tenaculum application and IUD placement; and 5 minutes after the procedure

Pulse rate was measured by the same researcher with the same device in both groups.

Before the procedure; immediately after speculum insertion, tenaculum application and IUD placement; and 5 minutes after the procedure
Respiratory rate (breaths per minute)
Lasso di tempo: Before the procedure and 5 minutes after the procedure

Respiratory rate was counted by the same researcher in both groups.

Before the procedure and 5 minutes after the procedure
Systolic and diastolic blood pressure (mmHg)
Lasso di tempo: Before the procedure and 5 minutes after the procedure

Blood pressure was measured by the same researcher with the same device in both groups.

Before the procedure and 5 minutes after the procedure
Duration of IUD insertion (minutes
Lasso di tempo: During the procedure

Time from the start to the end of the insertion procedure, recorded by the researcher in whole minutes.

During the procedure
Practitioner satisfaction with the procedure
Lasso di tempo: Immediately after the procedure

The practitioner performing the insertion rated overall satisfaction with the procedure on a single-item 100-mm visual analog scale from 0 (not at all satisfied) to 100 (completely satisfied).

Immediately after the procedure

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Cattedra di studio: Emine BAŞ, PhD, Sanko University
  • Cattedra di studio: Zeynep GÜNGÖRMÜŞ, Prof, Gaziantep Islam Science and Technology University
  • Investigatore principale: Yasemin ATEŞEYAN, PhD, MERSİN UNIVERSITY
  • Cattedra di studio: Esra VERİM, PhD, GAZİANTEP UNIVERSITY

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

  • Aydın, A., Araz, A., Asan, A. 2011. Görsel Analog Ölçeği ve Duygu Kafesi: Kültürümüze Uyarlama Çalışması, Türk Psikoloji Yazıları,14 (27), 1-13.
  • Kolcaba, K. (2003). Comfort Theory and Practice A vision for holistik health care and research, Springer Publishing Company. New York
  • Kuğuoğlu, S., & Karabacak, Ü. (2008). Genel Konfor Ölçeğinin Türkçe 'ye uyarlanması. İstanbul Üniversitesi Florence Nightingale Hemşirelik Yüksekokulu Dergisi, 61(16), 16-23.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

25 ottobre 2024

Completamento primario (Effettivo)

30 marzo 2025

Completamento dello studio (Effettivo)

10 marzo 2026

Date di iscrizione allo studio

Primo inviato

17 aprile 2026

Primo inviato che soddisfa i criteri di controllo qualità

5 maggio 2026

Primo Inserito (Effettivo)

12 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

3 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

30 ottobre 2026

Ultimo verificato

1 ottobre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Data are available from the corresponding author upon reasonable request because of privacy and ethical restrictions.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi